|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1331 Pennsylvania Ave NW |
Address2 | Suite 1425 North |
City | WASHINGTON |
State | DC |
Zip Code | 20004-1710 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Chicago |
State | IL |
Zip Code | 60601 |
Country | USA |
|
5. Senate ID# 2811-12
|
||||||||
|
6. House ID# 305490000
|
TYPE OF REPORT | 8. Year | 2024 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Paul G Billings |
Date | 4/22/2024 5:24:29 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Issues related to lung disease treatment, prevention and research; public health; tobacco control and air pollution; Issues related to the Affordable Care Act; Issues related to COVID-19 Response; Issues related to infrastructure; Issues relating to the Presidents FY25 budget; Issues relating to FY25 appropriations; HR 4368 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024; S.2131 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024; H.R. 4365 Department of Defense Appropriations Act, 2024; S 2624 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024; S 2605 Department of the Interior, Environment, and Related Agencies Appropriations Act; HR 4821 2024 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2024; HR 5894 Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes; ; HR 7463 Extension of Continuing Appropriations and Other Matters Act, 2024; HR 2872 Further Additional Continuing Appropriations and Other Extensions Act, 2024; HR4366 Consolidated Appropriations Act, 2024; HR 2882 Further Consolidated Appropriations Act, 2024
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), Centers For Disease Control & Prevention (CDC), Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Environmental Protection Agency (EPA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Billings |
|
|
|
Erika |
Sward |
|
|
|
Ranjana |
Caple |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CAW
16. Specific lobbying issues
Issues related to the health impacts of air pollution and climate change; Issues related to air pollution from stationary and mobile sources; Issues related to the Clean Air Act; Issues related to permitting and regulatory reforms; Issues related to infrastructure; Issues relating to the Presidents FY25 budget; Issues relating to FY25 appropriations; Issues related to implementation of the Inflation Reduction Act; Issues related to appliance efficiency; issues related to prescribed burning; HR 277 REINS Act; S 184 REINS Act; H.R. 165 New Source Review Permitting Improvement Act; S. 67 Fair and Transparent Gas Prices Act; S. 240 Gas Stove Protection and Freedom Act; HR 1615 Gas Stove Protection and Freedom Act; HR 1 Lower Energy Costs Act; HR 1435 to prevent the elimination of the sale of combustion vehicles; S 615 Cabin Air Safety Act; HR 1293 Cabin Air Safety Act; HR 1705 A. Donald McEachin Environmental Justice for All Act; S 919 A. Donald McEachin Environmental Justice for All Act; HR 1023 To repeal section 134 of the Clean Air Act, relating to the greenhouse gas reduction fund; HR 1131 To require the Administrator of the EPA to authorize the use of flexible air permitting with respect to certain critical energy resource facilities, and for other purposes; HR 1140 To authorize the Administrator of the EPA to waive application of certain requirements with respect to processing and refining a critical energy resource at a critical energy resource facility, and for other purposes; HR 1141 Natural Gas Tax Repeal Act;; S 1229 Green New Deal for Health; S. 1449RESTART ACT; S. 1399 Building American Energy Security Act of 2023; HR 1640Save Our Gas Stoves Act; S 1772Comprehensive National Mercury Monitoring Act; Promoting Efficient and Engaged Reviews (PEER) Act; S. 1930 Community Facilities Program for Rural Clean School Bus Infrastructure and Workforce Act; S 2179 Clean Cooking Support Act; H.R 4455 Community Facilities Program for Rural Clean School Buses Infrastructure Act; HR 3073 Community Mental Wellness and Resilience Act; S 1452 Community Mental Wellness and Resilience Act; HR 2811Limit Save Grow Act; HR 442 Regulatory Accountability Act; S 1615 Regulatory Accountability Act;; S. 2125 National Ambient Air Quality Standards Implementation Act of 2023; S. 2195 A bill to amend the Energy Policy Act of 2005 to reauthorize the diesel emissions reduction program; HR 288 Separation of Powers Restoration Act of 2023; HR 4211 Technology Assessment for Air Quality Management Act of 2023; S 2045 Technology Assessment for Air Quality Management Act of 2023; S 2624 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024; HJ Res 69 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "Federal 'Good Neighbor Plan' for the 2015 Ozone National Ambient Air Quality Standards"; SJ Res 31 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "Federal 'Good Neighbor Plan' for the 2015 Ozone National Ambient Air Quality Standards" S 2605 Department of the Interior, Environment, and Related Agencies Appropriations Act; HR 4821 2024 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2024; HR 4077 Cleaner Air Spaces Act of 2023; HR 5533 Healthy At Home Act; S 2834 Healthy At Home Act; HR 890 The Guidance Out of Darkness Act; S 791 The Guidance Out of Darkness Act; HR 1435 Preserving Choice in Vehicle Purchases Act; HR 4468 The Choice in Automobile Retail Sales Act of 2023; S 2333 Pandemic and All Hazards Preparedness and Response Act; HR 4420 Pandemic and All Hazards Preparedness and Response Act; HR 4820 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2024; S 2437 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2024; HR 4394 Energy and Water Development and Related Agencies Appropriations Act, 2024; S 2443 Energy and Water Development and Related Agencies Appropriations Act, 2024; SJ Res 11 a joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "Control of Air Pollution From New Motor Vehicles: Heavy-Duty Engine and Vehicle Standards"; S 2383 Smoke and Heat Ready Communities Act; HR 4733 Smoke and Heat Ready Communities Act; HR 5894 Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes; HR 6013 Promoting Reduction of Emissions through Landscaping Equipment Act; S 3371 Fostering Overseas Rule of Law and Environmentally Sound Trade (FOREST) Act; HR 357 Ensuring Accountability in Agency Rulemaking; HR 6621 Smoke Mitigation Occupational and Key Enhancements Act; S 3094 Choice in Automobile Retail Sales Act of 2023; ; HR 6192 Hands Off Our Home Appliances Act; HR 6421 Affordable HOMES Act; HR 7463 Extension of Continuing Appropriations and Other Matters Act, 2024; HR 2872 Further Additional Continuing Appropriations and Other Extensions Act, 2024; HR4366 Consolidated Appropriations Act, 2024; HR 2882 Further Consolidated Appropriations Act, 2024; SJ Res 38 A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Federal Highway Administration relating to Waiver of Buy America Requirements for Electric Vehicle Chargers; S 1863 PROVE It Act of 2024; S 2781 Good Samaritan Remediation of Abandoned Hardrock Mines Act; HR Res 987 Denouncing the harmful, anti-American energy policies of the Biden administration, and for other purposes; SJ Res 58 A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Energy relating to "Energy Conservation Program: Energy Conservation Standards for Consumer Furnaces"; HJ Res 11 Disapproving the rule submitted by the Department of Energy relating to "Energy Conservation Program: Energy Conservation Standards for Consumer Furnaces; HR 7193 Wildfire Air Quality Act; HR 7039 Stronger Communities Through Better Transit Act; HR7650 Air Quality Standards Implementation Act; S 3826 Modernizing Clean Air Permitting Act; HR Res 117Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "Reconsideration of the National Ambient Air Quality Standards for Particulate Matter"; HR 7673 Liberty in Laundry Act; HR 7645 Clothes Dryer Reliability Act; HR 7700 Stop the Unaffordable Dishwasher Standards Act; HR 7637 Refrigerator Freedom Act; HR 7626 Affordable Air Conditioning Act; HR 7526 DC Consumer Vehicle Choice Protection Act; HR 1023To repeal section 134 of the Clean Air Act, relating to the greenhouse gas reduction fund.; S 4072 A bill to prohibit the use of funds to implement, administer, or enforce certain rules of the Environmental Protection Agency; SJ Res 65A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "Reconsideration of the National Ambient Air Quality Standards for Particulate Matter"
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Environmental Protection Agency (EPA), Office of Management & Budget (OMB), White House Office, Centers For Disease Control & Prevention (CDC), Transportation - Dept of (DOT), Natl Highway Traffic Safety Administration (NHTSA), Council on Environmental Quality (CEQ), Interior - Dept of (DOI), Internal Revenue Service (IRS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Billings |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to tobacco cessation; Issues related to the Affordable Care Act; Issues related to the Childrens Health Insurance Program; Issues related to Medicaid; Issues related to ERISA; Issues related to COVID-19 Response; Issues related to vaccines; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to the implementation of the No Surprises Act; Issues related to Medicare sequestration; Issues related to Cancer Moonshot; Issues related to short-term limited duration plans; Issues related to Healthy Future Taskforce; Issues related to regulatory reform; Issues relating to the Presidents FY25 budget; Issues relating to FY25 appropriations; HR 277 REINS Act; S 184 REINS Act; HR 1075 Medicaid Work Requirements Act; S. 1063 A bill to amend title XIX of the Social Security Act to implement a minimum work requirement for able-bodied adults enrolled in State Medicaid programs; HR 1551 Jobs and Opportunities for Medicaid Act; H.R. 2583 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2023; H.R. 1114 Long COVID RECOVERY NOW Act; H.R. 1692 Health Care Affordability Act of 2023; HR 3073 Community Mental Wellness and Resilience Act; S 1452 Community Mental Wellness and Resilience Act; HR 2811 Limit Save Grow Act; HR 442 Regulatory Accountability Act; S 1615 Regulatory Accountability Act;; HR 288 Separation of Powers Restoration Act of 2023; Issues related to Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2024; S 1411, Prove It Act of 2023; S 1995 Public Health Infrastructure Saves Lives Act; HR 824 Telehealth Benefit Expansion for Workers Act of 2023; HR 4286 Increasing Access to Lung Cancer Screening Act; HR 2813 The Self-Insurance Protecon Act; HR 3799 CHOICE Arrangement Act; HR 2868 Association Health Plans Act; S 2213 Comprehensive Cancer Survivorship Act; HR 4363 Comprehensive Cancer Survivorship Act; S. 2016 CONNECT for Health Act of 2023; HR 4189 CONNECT for Health Act of 2023; S 2624 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024;; HR 5749 Family Asthma Act; HR 4286 Increasing Access to Lung Cancer Screening Act; HR 890 The Guidance Out of Darkness Act; S 791 The Guidance Out of Darkness Act; S 2245 Women and Lung Cancer Research and Preventive Services Act; HR 4534 Women and Lung Cancer Research and Preventive Services Act; S 2333 Pandemic and All Hazards Preparedness and Response Act; HR 4420 Pandemic and All-Hazards Preparedness and Response Act; S 1489 National Task Force on the COVID-19 Pandemic Act; HR 5894 Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes; HR 6302 Health Share Transparency Act; HR 357 Ensuring Accountability in Agency Rulemaking; ; HR 7463 Extension of Continuing Appropriations and Other Matters Act, 2024; HR 2872 Further Additional Continuing Appropriations and Other Extensions Act, 2024; HR4366 Consolidated Appropriations Act, 2024; HR 2882 Further Consolidated Appropriations Act, 2024; S3821 Supplemental Oxygen Access Reform (SOAR) Act; HR7829 Supplemental Oxygen Access Reform (SOAR) Act; HR 485 Protecting Health Care for All Patients Act of 2023
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), White House Office, Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Erika |
Sward |
|
|
|
Paul |
Billings |
|
|
|
Ranjana |
Caple |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
Issues relating to the Presidents FY25 budget; Issues relating to FY25 appropriations; Issues related to asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to lung disease treatment, prevention and research; Issues related to COVID-19; Issues related to telehealth; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to health equity; Issues related to Cancer Moonshot; Issues related to CDC public health workforce and data modernization; Issues related to regulatory reform; H.R. 833 Stop the Wait Act; Issues related to Medicaid; Issues related to Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2024; H.R. 4365 Department of Defense Appropriations Act, 2024;; S.2587 Department of Defense Appropriations Act, 2024; S 2624 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024; HR 890 The Guidance Out of Darkness Act; S 791 The Guidance Out of Darkness Act; HR 5894 Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes; HR 357 Ensuring Accountability in Agency Rulemaking; ; HR 7463 Extension of Continuing Appropriations and Other Matters Act, 2024; HR 2872 Further Additional Continuing Appropriations and Other Extensions Act, 2024; HR4366 Consolidated Appropriations Act, 2024; HR 2882 Further Consolidated Appropriations Act, 2024
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Disease Control & Prevention (CDC), Natl Institutes of Health (NIH), Health & Human Services - Dept of (HHS), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Erika |
Sward |
|
|
|
Paul |
Billings |
|
|
|
Ranjana |
Caple |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Issues related to lung disease treatment, prevention and research; Issues related to public health; Issues related to tobacco cessation; Issues related to health inequities; Issues related to Medicaid waivers; Issues related to the Affordable Care Act; Issues related to supplemental oxygen; Issues related to access to healthcare; Issues related to COVID-19 Response; Issues related to Medicaid; Issues related to infrastructure; Issues related to health equity; Issues related to the implementation of the No Surprises Act; Issues related to Medicaid; Issues relating to the Presidents FY25 budget; Issues related to regulatory reform; Issues relating to FY25 appropriations; HR 1075 Medicaid Work Requirements Act; S. 1063 A bill to amend title XIX of the Social Security Act to implement a minimum work requirement for able-bodied adults enrolled in State Medicaid programs; HR 1551 Jobs and Opportunities for Medicaid Act; H.R. 2583 Increasing Access to Quality Cardiac Rehabilitation Care Act of 2023; H.R. 1114 Long COVID RECOVERY NOW Act; H.R. 833 Stop the Wait Act; H.R. 2407 Nancy Garner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; HR 2811 Limit Save Grow Act; HR 442 Regulatory Accountability Act; S 1615 Regulatory Accountability Act;; HR 288 Separation of Powers Restoration Act of 2023; Issues related to Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2024; HR 4286 Increasing Access to Lung Cancer Screening Act; S. 2016 CONNECT for Health Act of 2023; HR 4189 CONNECT for Health Act of 2023; S 2624 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024;; HR 890 The Guidance Out of Darkness Act; S 791 The Guidance Out of Darkness Act; HR 5894 Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes; HR 357 Ensuring Accountability in Agency Rulemaking; HR 6693 Lung Cancer Screening and Prevention Act; ; HR 7463 Extension of Continuing Appropriations and Other Matters Act, 2024; HR 2872 Further Additional Continuing Appropriations and Other Extensions Act, 2024; HR4366 Consolidated Appropriations Act, 2024; HR 2882 Further Consolidated Appropriations Act, 2024; S3821 Supplemental Oxygen Access Reform (SOAR) Act; HR7829 Supplemental Oxygen Access Reform (SOAR) Act; HR 485 Protecting Health Care for All Patients Act of 2023
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), White House Office, Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Billings |
|
|
|
Erika |
Sward |
|
|
|
Ranjana |
Caple |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code POS
16. Specific lobbying issues
Issues related to nonprofit postal rates; Issues related to the Preventing Online Sales of E-cigarettes; HR 7463 Extension of Continuing Appropriations and Other Matters Act, 2024; HR 2872 Further Additional Continuing Appropriations and Other Extensions Act, 2024; HR4366 Consolidated Appropriations Act, 2024; HR 2882 Further Consolidated Appropriations Act, 2024
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, U.S. Postal Service (USPS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Billings |
|
|
|
Erika |
Sward |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
Issues related to lung cancer, lung disease treatment, prevention and research; and public health; Issues relating to the Presidents FY25 budget; Issues relating to FY25 appropriations; H.R. 4365 Department of Defense Appropriations Act, 2024; S.2587 Department of Defense Appropriations Act, 2024; ; HR 7463 Extension of Continuing Appropriations and Other Matters Act, 2024; HR 2872 Further Additional Continuing Appropriations and Other Extensions Act, 2024; HR4366 Consolidated Appropriations Act, 2024; HR 2882 Further Consolidated Appropriations Act, 2024
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Billings |
|
|
|
Erika |
Sward |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform; Issues relating to the Presidents FY24 budget; Issues relating to FY25 appropriations; HR 277 REINS Act; S 184 REINS Act; S. 107 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023; HR 901 To require the Food and Drug Administration to prioritize enforcement of disposable electronic nicotine delivery system products; S. 464 No Tax Subsidies for E-Cigarette and Tobacco Ads; HR 2811 Limit Save Grow Act; HR 442 Regulatory Accountability Act; S 1615 Regulatory Accountability Act;; HR 288 Separation of Powers Restoration Act of 2023; HR 4368 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024; S.2131 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024; HR 4020 Children Don't Belong on Tobacco Farms Act; Issues related to Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2024; S 1411, Prove It Act of 2023; HR 4286 Increasing Access to Lung Cancer Screening Act; S 2213 Comprehensive Cancer Survivorship Act; HR 4363 Comprehensive Cancer Survivorship Act; HR 2398 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes.; S 1040 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; S 2624 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024; ; HR 890 The Guidance Out of Darkness Act; S 791 The Guidance Out of Darkness Act; HR 4775 Helping Tobacco Users Quit Act; HR 5894 Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes; S 3108 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; HR 6038 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; HR 357 Ensuring Accountability in Agency Rulemaking; SJ Res 99 Exclude premium cigars from FDA oversight; ; HR 7463 Extension of Continuing Appropriations and Other Matters Act, 2024; HR 2872 Further Additional Continuing Appropriations and Other Extensions Act, 2024; HR4366 Consolidated Appropriations Act, 2024; HR 2882 Further Consolidated Appropriations Act, 2024; issues related to enforcement of illegal vaping;
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Food & Drug Administration (FDA), White House Office, Office of Management & Budget (OMB), Centers For Disease Control & Prevention (CDC), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Erika |
Sward |
|
|
|
Paul |
Billings |
|
|
|
Ranjana |
Caple |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Issues related to taxes on tobacco products; Issues related to the Affordable Care Act; Issues related to COVID-19; Issues related to infrastructure; Issues relating to the Presidents FY25 budget; S. 464 No Tax Subsidies for E-Cigarette and Tobacco Ads.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Erika |
Sward |
|
|
|
Paul |
Billings |
|
|
|
Ranjana |
Caple |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to COVID-19 Response; Issues relating to the Presidents FY24 budget; Issues relating to FY25 appropriations; ; HR 7463 Extension of Continuing Appropriations and Other Matters Act, 2024; HR 2872 Further Additional Continuing Appropriations and Other Extensions Act, 2024; HR4366 Consolidated Appropriations Act, 2024; HR 2882 Further Consolidated Appropriations Act, 2024
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Erika |
Sward |
|
|
|
Paul |
Billings |
|
|
|
Ranjana |
Caple |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |